Search Results - J. Levin
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
Flow Structure Investigation of a Truck under Crosswinds by J. Levin, S. H. Chen
Published in Journal of Applied Fluid Mechanics (2022-06-01)Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
-
8
Studies with herpes zoster vaccines in immune compromised patients by Myron J. Levin, Eddy Bresnitz, Zoran Popmihajlov, Adriana Weinberg, Kai-Li Liaw, English Willis, Jeffrey R. Curtis
Published in Expert Review of Vaccines (2017-12-01)Get full text
Article -
9
-
10
-
11
-
12
-
13
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influ... by Myron J. Levin, Victoria Divino, Drishti Shah, Mitch DeKoven, Joaquin Mould-Quevedo, Stephen I. Pelton, Maarten J. Postma
Published in Vaccines (2021-10-01)Get full text
Article -
14
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 an... by Myron J. Levin, Victoria Divino, Maarten J. Postma, Stephen I. Pelton, Zifan Zhou, Mitch DeKoven, Joaquin Mould-Quevedo
Published in Expert Review of Vaccines (2024-12-01)Get full text
Article -
15
A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States by Myron J. Levin, Neda Al Rawashdh, Liliane Mofor, Pablo Anaya, Richard M. Zur, Emily B. Kahn, Daniel Yu, Joaquin F. Mould-Quevedo
Published in Vaccines (2024-10-01)Get full text
Article -
16
Autoantibodies in Chagas' heart disease: possible markers of severe Chagas' heart complaint by M. J. Levin, G. Levitus, N. Kerner, S. Lafon, A. Schijman, P. Levy-Yeyati, C. Finkielstein, P. Chiale, D. Schejtman, M. Hontebeyrie-Joskowicz
Published in Memorias do Instituto Oswaldo Cruz (1990-12-01)Get full text
Article -
17
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses by David Fisman, Norberto Giglio, Myron J. Levin, Van Hung Nguyen, Stephen I. Pelton, Maarten Postma, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F. Mould-Quevedo
Published in Human Vaccines & Immunotherapeutics (2024-12-01)Get full text
Article -
18
Evaluation of two frailty indices, with practical application in a vaccine clinical trial by Desmond Curran, Melissa K. Andrew, Myron J. Levin, Elisa Turriani, Sean Matthews, Charles Fogarty, Nicola P. Klein, Katrijn Grupping, Lidia Oostvogels, Kenneth E. Schmader
Published in Human Vaccines & Immunotherapeutics (2019-12-01)Get full text
Article -
19
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials by Myron J. Levin, Andrew Ustianowski, Stephane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, Kanika Dey, Karen A. Near, Katie Streicher, Alexandre Kiazand, Mark T. Esser
Published in Infectious Diseases and Therapy (2024-05-01)Get full text
Article -
20
Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. by Adriana Weinberg, Petronella Muresan, Kelly M Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin, P1086 team
Published in PLoS ONE (2015-01-01)Get full text
Article
